How much do paid clinical trials in San Jose pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

Are clinical trials in San Jose safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

How do I join a study in San Jose, CA?

Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.

Is compensation for clinical trials taxable?

In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.

Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in San Jose typically complete one or two studies per year.

Paid Clinical Trials San Jose, CA — 1124 Studies Recruiting (Oct 2026)

Decreasing Emergence Agitation With Personalized Music

Surgical Procedure, Unspecified N/A Interventional 100 participants sought

Stanford University — Stanford, California (19.4 mi) · Sponsor: Stanford University

See eligibility & contact on ClinicalTrials.gov (NCT05044832)

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia Phase 1 Interventional 40 participants sought

Stanford University: Stanford Children's Health — Redwood City, California (24.8 mi) · Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois

See eligibility & contact on ClinicalTrials.gov (NCT05500807)

Study of Cryoablation and Nirogacestat for Desmoid Tumor

Desmoid Tumor Phase 2 Interventional 28 participants sought

Stanford University — Palo Alto, California (18.9 mi) · Sponsor: Nam Bui

See eligibility & contact on ClinicalTrials.gov (NCT05949099)

Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic

Spinal Cord Injury, Pressure Injury N/A Interventional 808 participants sought

VA Palo Alto Health Care System, Palo Alto, CA — Palo Alto, California (18.9 mi) · Sponsor: VA Office of Research and Development

See eligibility & contact on ClinicalTrials.gov (NCT06529094)

SWIR Otoscopy Study

Otitis Media, Otitis Media Chronic N/A Interventional 100 participants sought

Stanford University — Palo Alto, California (18.9 mi) · Sponsor: Stanford University

See eligibility & contact on ClinicalTrials.gov (NCT06944795)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought

Stanford Women's Cancer Center — Palo Alto, California (18.9 mi) · Sponsor: Relay Therapeutics, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT06982521)

SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma

Epithelioid Hemangioendothelioma (EHE) Phase 2 Interventional 41 participants sought

Stanford University — Stanford, California (19.4 mi) · Sponsor: Sarcoma Alliance for Research through Collaboration

See eligibility & contact on ClinicalTrials.gov (NCT07104331)

GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus N/A Interventional 400 participants sought

Stanford University Medical Center — Stanford, California (19.4 mi) · Sponsor: Medtronic MiniMed, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07228117)

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

Chronic Inducible Urticaria, Cold Urticaria Phase 3 Interventional 240 participants sought

Allergy & Asthma Consultants — Redwood City, California (24.8 mi) · Sponsor: Celldex Therapeutics

See eligibility & contact on ClinicalTrials.gov (NCT07266402)

The Pediatric Anesthesia Quality Improvement Project

Surgery, Anesthesia N/A Observational 5,000,000 participants sought

Lucile Packard Children's Hospital Stanford — Palo Alto, California (18.9 mi) · Sponsor: The Society for Pediatric Anesthesia

See eligibility & contact on ClinicalTrials.gov (NCT00674388)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought

Kaiser Permanente-Santa Teresa-San Jose — San Jose, California (3.7 mi) · Sponsor: SWOG Cancer Research Network

See eligibility & contact on ClinicalTrials.gov (NCT03851445)

Zenith® Fenestrated+ Clinical Study

Aortic Aneurysm, Abdominal, Juxtarenal Aortic Aneurysm N/A Interventional 105 participants sought

Stanford Hospitals and Clinics — Stanford, California (19.4 mi) · Sponsor: Cook Research Incorporated

See eligibility & contact on ClinicalTrials.gov (NCT04875429)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought

Lucile Packard Children's Hospital Stanford University — Palo Alto, California (18.9 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT06124157)

REHAB Fontan Failure: A Trial of Cardiac Rehabilitation

Heart Failure Congenital, Single-ventricle N/A Interventional 50 participants sought

Stanford University — Stanford, California (19.4 mi) · Sponsor: Stanford University

See eligibility & contact on ClinicalTrials.gov (NCT06150950)

Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)

Diabetes Mellitus, Type 2 N/A Interventional 119,680 participants sought

Board of Trustees of the Leland Stanford Junior University — Stanford, California (19.4 mi) · Sponsor: Stanford University

See eligibility & contact on ClinicalTrials.gov (NCT06251323)

Prehabilitation and Rehabilitation in PAD

Peripheral Arterial Disease N/A Interventional 300 participants sought

VA Palo Alto Health Care System — Palo Alto, California (18.9 mi) · Sponsor: Palo Alto Veterans Institute for Research

See eligibility & contact on ClinicalTrials.gov (NCT06566976)

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Breast Cancer Phase 3 Interventional 450 participants sought

Palo Alto Medical Foundation Research Center — Sunnyvale, California (11.4 mi) · Sponsor: Hoffmann-La Roche

See eligibility & contact on ClinicalTrials.gov (NCT06790693)

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer Phase 3 Interventional 600 participants sought

Palo Alto Medical Foundation Research Center — Palo Alto, California (18.9 mi) · Sponsor: Hoffmann-La Roche

See eligibility & contact on ClinicalTrials.gov (NCT06793215)

Nutrition OUtReach In Systems of Healthcare

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Autologous Haemopoietic Stem Cell Transplant N/A Interventional 210 participants sought

Stanford University — Stanford, California (19.4 mi) · Sponsor: University of Kansas Medical Center

See eligibility & contact on ClinicalTrials.gov (NCT06802406)

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Colitis, Ulcerative Phase 3 Interventional 882 participants sought

Stanford Medicine Children's Health — Palo Alto, California (18.9 mi) · Sponsor: Janssen Research & Development, LLC

See eligibility & contact on ClinicalTrials.gov (NCT07196748)

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

Mycosis Fungoides, Non-Hodgkin's Lymphoma N/A Observational 2,000 participants sought

Stanford University, School of Medicine — Palo Alto, California (18.9 mi) · Sponsor: Stanford University

See eligibility & contact on ClinicalTrials.gov (NCT02848274)

Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections

Pulmonary Invasive Fungal Infections, Pulmonary Invasive Aspergillosis N/A Observational 400 participants sought

Lucile Packard Children's Hospital, Stanford University — Palo Alto, California (18.9 mi) · Sponsor: Arkansas Children's Hospital Research Institute

See eligibility & contact on ClinicalTrials.gov (NCT03827694)

A Study of Esomeprazole in Children With Autism

Autism, Autism Spectrum Disorder Phase 2 Interventional 25 participants sought

Stanford University School of Medicine — Stanford, California (19.4 mi) · Sponsor: Stanford University

See eligibility & contact on ClinicalTrials.gov (NCT03866668)

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought

Epic Care-Dublin — Dublin, California (28.1 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

See eligibility & contact on ClinicalTrials.gov (NCT03937635)

Clinical Translation of a Novel Brain PET Insert for Simultaneous PET/MR

Brain Disease N/A Interventional 40 participants sought

Stanford University — Palo Alto, California (18.9 mi) · Sponsor: Stanford University

See eligibility & contact on ClinicalTrials.gov (NCT04383808)

Paid Clinical Trials in San Jose, CA

Studies recruiting near San Jose right now

Decreasing Emergence Agitation With Personalized Music

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

Study of Cryoablation and Nirogacestat for Desmoid Tumor

Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic

SWIR Otoscopy Study

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma

GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

The Pediatric Anesthesia Quality Improvement Project

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Zenith® Fenestrated+ Clinical Study

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

REHAB Fontan Failure: A Trial of Cardiac Rehabilitation

Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)

Prehabilitation and Rehabilitation in PAD

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Nutrition OUtReach In Systems of Healthcare

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections

A Study of Esomeprazole in Children With Autism

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Clinical Translation of a Novel Brain PET Insert for Simultaneous PET/MR

Studies you may be able to join near San Jose

See which clinical studies you may qualify for

Top-rated research centers in San Jose

Lumos Clinical Research Center

San Jose Clinical Trials

Silicon Valley Research Center

IBM Research - Almaden Lab

Dr. Syverain San Jose

Molecular Medicine Research Institute

Cancer Clinical Trials Office, Stanford Cancer Institute

OIRRC

Vibrant Wellness

Clinical trials in San Jose: what's recruiting

How to enroll in a paid study in San Jose

Frequently asked questions

Paid clinical trials near San Jose

By condition

More of CA

New paid studies open every week